Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Hsiehchen · SciRah

Researcher profile · Semantic Scholar

D. Hsiehchen

Share profile

D. Hsiehchen — researcher profile on SciRah

h-index: 23
Works: 89
Citations: 1,853

Most-cited papers

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial.
S. Qin, Min-Shan Chen, A. Cheng, A. Kaseb +20 more
2023The Lancet400 citations Open access
Semantic Scholar
Multinational teams and diseconomies of scale in collaborative research
D. Hsiehchen, M. Espinoza, Antony Hsieh
2015Science Advances82 citations Open access
Semantic Scholar
Variation in the Assessment of Immune-Related Adverse Event Occurrence, Grade, and Timing in Patients Receiving Immune Checkpoint Inhibitors
D. Hsiehchen, M. Watters, Rong Lu, Yang Xie +1 more
2019JAMA Network Open81 citations Open access
Semantic Scholar
Association between immune-related adverse event timing and treatment outcomes
D. Hsiehchen, A. Naqash, M. Espinoza, M. V. von Itzstein +8 more
2022Oncoimmunology70 citations Open access
Semantic Scholar
DNA Repair Gene Mutations as Predictors of Immune Checkpoint Inhibitor Response beyond Tumor Mutation Burden
D. Hsiehchen, Antony Hsieh, R. Samstein, Tian-Shi Lu +5 more
2020Cell Reports Medicine67 citations Open access
Semantic Scholar
Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma
B. Scheiner, D. Roessler, S. Phen, Mir Lim +34 more
2022JHEP Reports65 citations Open access
Semantic Scholar
Political partisanship and mobility restriction during the COVID-19 pandemic
D. Hsiehchen, M. Espinoza, P. Slovic
2020Public Health65 citations Open access
Semantic Scholar
Multidisciplinary care for patients with HCC: a systematic review and meta-analysis
Karim Seif El Dahan, A. Reczek, Darine Daher, N. Rich +10 more
2023Hepatology Communications56 citations Open access
Semantic Scholar
Disease etiology and outcomes after atezolizumab plus bevacizumab in hepatocellular carcinoma: Post-hoc analysis of IMbrave150.
M. Espinoza, Maishara Muiquith, Mir Lim, Hao Zhu +2 more
2023Gastroenterology52 citations
Semantic Scholar
Association between body mass index, dosing strategy, and efficacy of immune checkpoint inhibitors
Murtaza Ahmed, M. V. von Itzstein, Tommy Sheffield, Shaheen Khan +13 more
2021Journal for ImmunoTherapy of Cancer42 citations Open access
Semantic Scholar
The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial
D. Hsiehchen, M. S. Beg, R. Kainthla, J. Lohrey +20 more
2024Nature Communications36 citations Open access
Semantic Scholar
Tissue-specific thresholds of mutation burden associated with anti-PD-1/L1 therapy benefit and prognosis in microsatellite-stable cancers
M. Muquith, Magdalena Espinoza, A. Elliott, J. Xiu +16 more
2024Nature Cancer34 citations
Semantic Scholar
Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma
S. Alden, Mir Lim, Chester Kao, Daniel H. Shu +8 more
2023Cancer Research Communications33 citations Open access
Semantic Scholar
Characterization of Plasma Cell-Free DNA Variants as of Tumor or Clonal Hematopoiesis Origin in 16,812 Advanced Cancer Patients
Dan Magee, V. Domenyuk, J. Abraham, Nieves Perdigones Borderias +23 more
2025Clinical Cancer Research32 citations Open access
Semantic Scholar
Clinical Outcomes in Fibrolamellar Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors
Krista Y Chen, A. Popovic, D. Hsiehchen, M. Baretti +7 more
2022Cancers30 citations Open access
Semantic Scholar
Clinical Efficiency and Safety Outcomes of Virtual Care for Oncology Patients During the COVID-19 Pandemic
D. Hsiehchen, M. Muquith, W. Haque, M. Espinoza +2 more
2021JCO Oncology Practice30 citations Open access
Semantic Scholar
Devimistat in combination with gemcitabine and cisplatin in biliary tract cancer: Pre-clinical evaluation and phase 1b multicenter clinical trial (BilT-04)
Arathi Mohan, K. Griffith, F. Wuchu, D. Zhen +14 more
2023Clinical Cancer Research28 citations Open access
Semantic Scholar
Transparency, Accessibility, and Variability of US Hospital Price Data
W. Haque, Muzzammil Ahmadzada, Hassan Allahrakha, Eman F. Haque +1 more
2021JAMA Network Open28 citations Open access
Semantic Scholar
Adherence to a Federal Hospital Price Transparency Rule and Associated Financial and Marketplace Factors.
W. Haque, Muzzammil Ahmadzada, Sanjana Janumpally, Eman F. Haque +3 more
2022Journal of the American Medical Association (JAMA)27 citations Open access
Semantic Scholar
Biomarkers for RBM39 degradation in acute myeloid leukemia
D. Hsiehchen, Margaret A. Goralski, Jiwoong Kim, Yang Xie +1 more
2020Leukemia25 citations Open access
Semantic Scholar
Trends and clinical features of intentional and accidental adult foreign body ingestions in the United States, 2000 to 2017.
Antony Hsieh, D. Hsiehchen, Sabrina Layne, G. Ginsberg +1 more
2020Gastrointestinal Endoscopy25 citations
Semantic Scholar
Prevalence of Female Authors in Case Reports Published in the Medical Literature
D. Hsiehchen, Antony Hsieh, M. Espinoza
2019JAMA Network Open24 citations Open access
Semantic Scholar
Association between Antibiotic Exposure and Systemic Immune Parameters in Cancer Patients Receiving Checkpoint Inhibitor Therapy
M. V. von Itzstein, Amrit S. Gonugunta, Tommy Sheffield, J. Homsi +17 more
2022Cancers23 citations Open access
Semantic Scholar
Clonal hematopoiesis and differential outcomes after immune checkpoint blockade
D. Hsiehchen, H. J. Sfreddo, Karena L Zhao, C. Han +1 more
2022Cancer Cell22 citations Open access
Semantic Scholar
EGFR/ERBB2 amplifications and alterations associated with resistance to lenvatinib in hepatocellular carcinoma.
Mir Lim, J. Franses, Robin Imperial, U. Majeed +2 more
2023Gastroenterology21 citations Open access
Semantic Scholar
PBRM1 mutations might render a subtype of biliary tract cancers sensitive to drugs targeting the DNA damage repair system
K. Zimmer, F. Kocher, G. Untergasser, B. Kircher +26 more
2023npj Precision Oncology21 citations Open access
Semantic Scholar
Impact of tumor mutational burden on checkpoint inhibitor drug eligibility and outcomes across racial groups
D. Hsiehchen, M. Espinoza, C. Valero, C. Ahn +1 more
2021Journal for ImmunoTherapy of Cancer20 citations Open access
Semantic Scholar
Surrogate and modified endpoints for immunotherapy in advanced hepatocellular carcinoma
Mir Lim, M. Muquith, Bernadette Miramontes, Chieh-Ju Lee +3 more
2023Hepatology19 citations
Semantic Scholar
Characteristics and clinical outcomes in young‐onset cholangiocarcinoma
Sarah Reddy, S. Goksu, N. Sanford, R. Kainthla +8 more
2023Cancer Medicine19 citations Open access
Semantic Scholar
Characteristics of Faculty Accused of Academic Sexual Misconduct in the Biomedical and Health Sciences.
M. Espinoza, D. Hsiehchen
2020Journal of the American Medical Association (JAMA)19 citations Open access
Semantic Scholar
Immune Checkpoint Inhibition is Safe and Effective for Liver Cancer Prevention in a Mouse Model of Hepatocellular Carcinoma
A. Chung, Marcel Mettlen, Debolina Ganguly, Tian-Shi Lu +4 more
2020Cancer Prevention Research19 citations Open access
Semantic Scholar
Clinical and biological determinants of circulating tumor DNA detection and prognostication using a next-generation sequencing panel assay
D. Hsiehchen, M. Espinoza, D. Gerber, M. Beg
2021Cancer Biology & Therapy18 citations Open access
Semantic Scholar
Dual TIGIT and PD-1 blockade with domvanalimab plus zimberelimab in hepatocellular carcinoma refractory to anti-PD-1 therapies: the phase 2 LIVERTI trial
D. Hsiehchen, R. Kainthla, Heather Kline, Ellen Siglinsky +2 more
2025Nature Communications17 citations Open access
Semantic Scholar
Genetic features and therapeutic relevance of emergent circulating tumor DNA alterations in refractory non-colorectal gastrointestinal cancers
D. Hsiehchen, L. Bucheit, Dong Yang, M. Beg +5 more
2022Nature Communications17 citations Open access
Semantic Scholar
Nearing saturation of cancer driver gene discovery
D. Hsiehchen, Antony Hsieh
2018Journal of Human Genetics16 citations
Semantic Scholar
Complete Response to Immunotherapy in Patients With Hepatocellular Carcinoma
Mir Lim, Magdalena Espinoza, Yi-Hsiang Huang, J. Franses +2 more
2025JAMA Network Open15 citations Open access
Semantic Scholar
Nonresearch Pharmaceutical Industry Payments to Oncology Physician Editors.
W. Haque, M. Alvarenga, D. Hsiehchen
2020The Oncologist14 citations Open access
Semantic Scholar
Antibiotic Prescriptions in Lung Cancer and Melanoma Populations: Differences With Potential Clinical Implications in the Immunotherapy Era.
Amrit S. Gonugunta, M. V. von Itzstein, D. Hsiehchen, Tri Le +5 more
2022Clinical Lung Cancer12 citations Open access
Semantic Scholar
Distinct Clinical Characteristics in Young-Onset Pancreatic Neuroendocrine Tumor
S. Goksu, Muhammet Ozer, Syed M. Kazmi, N. Sanford +8 more
2020Cancers12 citations Open access
Semantic Scholar
Ibrutinib Use Complicated by Progressive Multifocal Leukoencephalopathy
D. Hsiehchen, R. Arasaratnam, K. Raj, T. Froehlich +1 more
2018Oncology12 citations
Semantic Scholar
The Cooperative Landscape of Multinational Clinical Trials
D. Hsiehchen, M. Espinoza, Antony Hsieh
2015PLoS ONE12 citations Open access
Semantic Scholar
Deficiencies in the Designs and Interventions of COVID-19 Clinical Trials
D. Hsiehchen, M. Espinoza, Antony Hsieh
2020i Medicina11 citations Open access
Semantic Scholar
Racial Disparities in Time to Treatment Initiation and Outcomes for Early-Stage Anal Squamous Cell Carcinoma
S. Goksu, Muhammet Ozer, S. Kazmi, T. Aguilera +6 more
2020American Journal of Clinical Oncology11 citations Open access
Semantic Scholar
Racial/Ethnic Disparities and Survival Characteristics in Non-Pancreatic Gastrointestinal Tract Neuroendocrine Tumors
S. Goksu, Muhammet Ozer, M. Beg, N. Sanford +9 more
2020Cancers10 citations Open access
Semantic Scholar
pan-MHC and cross-Species Prediction of T Cell Receptor-Antigen Binding
Yi Han, Yu-Qiu Yang, Yan-Hua Tian, F. Fattah +29 more
2023bioRxiv9 citations Open access
Semantic Scholar
T-cell tolerant fraction as a predictor of immune-related adverse events
Jared Ostmeyer, Jason Y. Park, M. V. von Itzstein, D. Hsiehchen +8 more
2023Journal for ImmunoTherapy of Cancer9 citations Open access
Semantic Scholar
Profile and Predictors of Blood Tumor Mutational Burden in Advanced Hepatocellular Carcinoma
J. Franses, Mir Lim, Adam M. Burgoyne, K. Mody +8 more
2022The Oncologist9 citations Open access
Semantic Scholar
PKD1 mutant clones within cirrhotic livers inhibit steatohepatitis without promoting cancer
Min Zhu, Yunguan Wang, Tian-Shi Lu, Jason Guo +16 more
2024Cell Metabolism8 citations Open access
Semantic Scholar
Oncogenic RAS drives resistance to pemigatinib in cholangiocarcinoma harboring a FGFR2 delins disrupting ligand binding
Mir Lim, P. T. Lynch, Xiao-Chen Bai, D. Hsiehchen
2023JCO Precision Oncology8 citations
Semantic Scholar
Representation of Investigators by Gender Among Authors of Phase 3 Oncology Trials Worldwide
M. Muquith, Tri Pham, M. Espinoza, D. Hsiehchen
2022JAMA Network Open8 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Espinoza×13
Invite
M. Espinoza — researcher profile on SciRah
D. Gerber×8
Invite
D. Gerber — researcher profile on SciRah
M. Beg×8
Invite
M. Beg — researcher profile on SciRah
Mir Lim×8
Invite
Mir Lim — researcher profile on SciRah

×7

Invite

Antony Hsieh — researcher profile on SciRah

M. V. von Itzstein×6

Invite

M. V. von Itzstein — researcher profile on SciRah

Invite

A. Yopp — researcher profile on SciRah

Invite

Yang Xie — researcher profile on SciRah

Invite

N. Sanford — researcher profile on SciRah

Invite

C. Ahn — researcher profile on SciRah

Invite

F. Fattah — researcher profile on SciRah

Invite

R. Kainthla — researcher profile on SciRah